Aclaris Therapeutics Inc
ACRS
Market Cap$155.92M
Close$
$1.82
38.7% upside
Current Fair Value
38.7% upsideUndervalued by 38.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $155.92 Million |
|---|---|
| Enterprise Value | $135.24 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.71 |
| Beta | 0.54 |
| Outstanding Shares | 95,305,768 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.04 |
|---|---|
| PEG | 1.4 |
| Price to Sales | - |
| Price to Book Ratio | 1.31 |
| Enterprise Value to Revenue | 4.99 |
| Enterprise Value to EBIT | -1.69 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aclaris Therapeutics Inc
CEO: Neal Walker